Viewing nowGasron Tablet 4mg (Irsogladine Maleate)
Irsogladine Maleate 4mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

MFDS item code 200700633 · Approved 2007.01.17 · Insurance code 650100040
Improvement of gastric mucosal lesions (erosions, bleeding, etc.) in gastritis; treatment of gastric ulcers
This medication is used to treat gastric ulcers and helps improve conditions such as erosion, bleeding, redness, and swelling of the gastric mucosa that occur during exacerbation of acute gastritis and chronic gastritis. Therefore, it protects the gastric mucosa and helps recover damaged areas, improving gastric health.
Use as follows for each condition. Adjust the dose as appropriate according to symptoms. 1) Gastric ulcer (Adults) Administer 4 mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4 mg of irsogladine maleate orally in 1~2 divided doses daily.
This medication contains lactose, and should not be used by patients with genetic issues such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption. When taking this medication, side effects such as liver function abnormalities, constipation, rash, itching, and diarrhea may occur, so patients should closely monitor their condition. In particular, liver function test results may increase, so regular testing may be required. Elderly patients may have diminished bodily functions, so it should be initiated at a low dose while closely monitoring their condition. Women who are pregnant or may become pregnant should only use this medication when the benefits outweigh the risks, as safety during pregnancy is still not confirmed. Lactating women should avoid using this medication if possible, or if it is necessary, they should stop breastfeeding since it may be partially excreted in breast milk. Caution is required as the safety of this medication in children has not been sufficiently confirmed. This medication should be kept out of the reach of children, and transferring it to another container is not advisable for quality maintenance and safety reasons.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. The recommended storage temperature is between 1°C and 30°C. This will help maintain the medication’s efficacy and safety.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrsogladine Maleate 4mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Orally disintegrating Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Dong-gu Bio Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Ilyun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
(Co., Ltd.) Nexpharm Korea
Irsogladine Maleate 2mg
Tablet · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.